NCT03653507 2026-04-17GLOWAstellas Pharma IncPhase 3 Active not recruiting507 enrolled 65 charts 3 FDA
NCT04661150 2026-04-16A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal JunctionHoffmann-La RochePhase 2 Active not recruiting42 enrolled 9 charts
NCT04736485 2026-04-14GASPARCentre Francois BaclessePhase 2 Active not recruiting67 enrolled 10 charts
NCT02782949 2026-04-02Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal MetaplasiaNational Cancer Institute (NCI)Phase 2 Active not recruiting50 enrolled 10 charts
NCT04234113 2026-03-27Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsSotio Biotech Inc.Phase 1 Terminated115 enrolled 43 charts